Accumulation of the beta(2)-adrenoceptor agonist clenbuterol in calf hair of different pigmentation

被引:0
|
作者
Gleixner, A
Sauerwein, H
Meyer, HHD
机构
来源
ARCHIV FUR LEBENSMITTELHYGIENE | 1996年 / 47卷 / 06期
关键词
D O I
暂无
中图分类号
O69 [应用化学];
学科分类号
081704 ;
摘要
The objective of this study was to develop an analytical approach to detect the illegal application of Clenbuterol in cattle as an anabolic agent by hair analysis. Special emphasis was layed on the time course of the incorporation of Clenbuterol into growing hair and on the influence of hair pigmentation on Clenbuterol concentrations in hair. Twelve male veal calves of different coal color were fed with .8 mu g of Clenbuterol/kg BW, twice daily, for 10 d as prescribed for the therapeutic use that is registered in most European countries. During and after the treatment hair samples were obtained and analyzed for Clenbuterol residues. An appropriate method to extract Clenbuterol from hair for subsequent enzyme immunological quantification was developed. Clenbuterol residues could be detected in hair from d 4 (similar to 1 ng/g) of the treatment to d 60 after the end of treatment (similar to 20 ng/g). The accumulation of Clenbuterol was considerably higher in black hair (similar to 100 ng/g) than in lighter colored hair (similar to 5 ng/g) demonstrating the importance of hair pigmentation for the binding of Clenbuterol to the hair matrix. During d 11 to 25 of the experiment most of the incorporated Clenbuterol could be detected in the hair fiber (similar to 300 ng/g for black hair vs. similar to 20 ng/g for lighter colored hair). Our results suggested that hair analysis is a powerful mean to detect and track the illegal use of Clenbuterol in animal production.
引用
收藏
页码:131 / 135
页数:5
相关论文
共 50 条
  • [31] EFFECT OF THE BETA-ADRENOCEPTOR AGONIST CLENBUTEROL AND PHYTOHEMAGGLUTININ ON GROWTH, PROTEIN-SYNTHESIS AND POLYAMINE METABOLISM OF TISSUES OF THE RAT
    BARDOCZ, S
    BROWN, DS
    GRANT, G
    PUSZTAI, A
    STEWART, JC
    PALMER, RM
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 106 (02) : 476 - 482
  • [32] STUDIES ON THE SELECTIVE BETA-2-ADRENOCEPTOR AGONIST, TULOBUTEROL
    KAWAMOTO, H
    MASHIBA, H
    HAYASHIBARA, H
    ISHIZASHI, A
    ITO, T
    FOLIA PHARMACOLOGICA JAPONICA, 1983, 82 (02) : P99 - P100
  • [33] Radioiodination and Biological Evaluation of Salbutamol as a beta(2)-Adrenoceptor Agonist
    El-Tawoosy, M.
    Ibrahim, I. T.
    RADIOCHEMISTRY, 2012, 54 (04) : 401 - 406
  • [34] Effects of drugs which influence renal transport systems on the urinary excretion of the beta(2)-adrenoceptor agonist clenbuterol and the anabolic steroids ethinylestradiol and methyltestosterone
    Gleixner, A
    Sauerwein, H
    Meyer, HHD
    FOOD ADDITIVES AND CONTAMINANTS, 1997, 14 (02): : 143 - 150
  • [35] beta(2) adrenoceptor agonist/antagonist activity of formoterol and salmeterol
    Jonkers, RE
    Koopmans, RP
    THORAX, 1997, 52 (03) : 305 - 305
  • [36] MODULATION OF IGE PRODUCTION IN THE MOUSE BY BETA(2)-ADRENOCEPTOR AGONIST
    COQUERET, O
    PETITFRERE, C
    LAGENTE, V
    MOUMEN, M
    MENCIAHUERTA, JM
    BRAQUET, P
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1994, 105 (02) : 171 - 176
  • [37] Functional desensitization of the beta(2) adrenoceptor is not dependent on agonist efficacy
    Rosethorne, Elizabeth M.
    Bradley, Michelle E.
    Kent, Toby C.
    Charlton, Steven J.
    PHARMACOLOGY RESEARCH & PERSPECTIVES, 2015, 3 (01): : 1 - 13
  • [38] ANABOLIC EFFECTS OF CLENBUTEROL ON SKELETAL-MUSCLE ARE MEDIATED BY BETA(2)-ADRENOCEPTOR ACTIVATION
    CHOO, JJ
    HORAN, MA
    LITTLE, RA
    ROTHWELL, NJ
    AMERICAN JOURNAL OF PHYSIOLOGY, 1992, 263 (01): : E50 - E56
  • [39] EFFECTS OF CLENBUTEROL, A BETA-2-ADRENERGIC AGONIST, IN THE PERFUSED CAT EYE
    GERBER, U
    NIEMEYER, G
    KLINISCHE MONATSBLATTER FUR AUGENHEILKUNDE, 1987, 190 (04) : 238 - 240
  • [40] ANTI-ALLERGIC ACTIVITY OF AN ORAL BETA-2 AGONIST, CLENBUTEROL
    FABRE, J
    BOUSQUET, J
    LEBEL, B
    JIROUNAJOU, JL
    CLUZEL, M
    GODARD, P
    MICHEL, FB
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (01) : 311 - 311